GSK, AstraZeneca and Labcyte Form Alliance to Develop Acoustic Mass Spectrometry

News   Oct 04, 2017 | Original story from Labcyte

 
GSK, AstraZeneca and Labcyte Form Alliance to Develop Acoustic Mass Spectrometry
 
 
 

RELATED ARTICLES

Funding Approved to Further Metabolomics Research

News

The NIH Common Fund Metabolomics Program has been approved for a second stage of support from fiscal years 2018-2021.

READ MORE

Two Studies Provide Significant Hope in the Fight Against Antibiotic Resistance

News

Two recent studies led by the University of Bristol provide significant new hope in the fight against antibiotic resistance.

READ MORE

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE